Edwards Lifesciences to Acquire Innovalve
Edwards Lifesciences announced on July 15 that it has exercised its option to acquire Innovalve Bio Medical Ltd. following its initial investment in 2017. The purchase price is about $300 million in cash. Innovalve Bio Medical Ltd. is an early-stage medical device company that develops catheter-based heart valve therapies. The company was founded in 2017 and is based in Israel. Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via... Read More »
PE-Backed Riverpoint Medical Acquires CP Medical
Riverpoint Medical announced that it has completed the acquisition of CP Medical. Riverpoint is a portfolio company of Arlington Capital Partners, a Washington, D.C.-area private investment firm specializing in government-regulated industries. CP Medical is a Norcross, Georgia-based manufacturer of surgical solutions, specializing in products for wound closure as well as for specialty surgical applications. CP Medical also manufactures a comprehensive portfolio of private-label sutures and wound closure products, sold through a global network of distributors, for the veterinary and human medical market. Headquartered in Portland, Oregon, Riverpoint Medical is a developer, designer and... Read More »
Boston Scientific Acquires Silk Road Medical in California
Boston Scientific announced on June 18 the acquisition of Silk Road Medical, located in Sunnyvale, California. Boston Scientific said it would pay $27.50 per share for Silk Road, totaling $1.16 billion. The California company’s shares were priced at $26.84 at midday Tuesday. Silk Road Medical is a medical device company that is focused on reducing the risk of stroke and its impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery... Read More »
PE Firm GTCR Acquires Surmodics for Approximately $627 Million
Surmodics, Inc. announced on May 29 that it has entered into a definitive agreement to be acquired by GTCR, a leading private equity firm with a long track record of investment expertise across healthcare and healthcare technology. Under the terms of the agreement, affiliates of GTCR will acquire all outstanding shares of Surmodics. Surmodics shareholders will receive $43.00 per share in cash, for a total equity valuation of approximately $627 million. Surmodics is an Eden Prairie, Minnesota-based provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also... Read More »
Innara Health Acquired by Previous Investor Cardinal Health
Innara Health announced on May 14 that it has been acquired by one of its previous investors, global healthcare company Cardinal Health Inc. Innara Health was founded in Kansas, Olathe in 2012 after it bought the physical and intellectual property for the NTrainer system from KC Biomedix. Innara is a neonatal medical device company developing feeding technology for premature infants, full infants, newborns and children. Cardinal Health invested an undisclosed amount in Innara in April 2022. Cardinal Health is an American multinational healthcare services company, and the 14th-highest revenue-generating company in the United States. Cardinal Health provides pharmaceutical and medical... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
